Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
5 Features to Look for in Your Next eTMF
Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.
-
Measuring Critical Health Outcomes In Obesity Treatments
Uncover how wearable technologies are helping advance digital health measures in obesity research and contribute to the development of more effective, sustainable obesity treatments.
-
Rare Disease Clinical Trials: Modern Design And Supply Chain
Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.
-
Taking eCOA Technology Deployment Off The Critical Path
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
CAR T Study For Blockbuster Drug Granted Therapy Designation
Discover how a pharmaceutical sponsor received support for an EDC and IRT database build and got help with data management and biostatistics.
-
Televisits: Why Integrate Telemedecine Features In eCOA Trials?
Discover new possibilities where patients can complete several of their clinical study procedures remotely, making their participation in clinical trials easier and less cumbersome than site-based trials.
-
eReg Benefits For Clinical Research: Use Cases For All Types Of Sites
Unearth the different kinds of eRegulatory use cases for diverse clinical site types and other eRegulatory capabilities designed to serve all sites.
-
eConsent: The Missing Ingredient To More Engaging Clinical Trials
Electronic consent promotes better trial experiences, but many sites and sponsors are wary of giving up paper-based processes. Consider their reasons for caution and how teams can prepare for the switch.
-
Using RWE To Get To Insights And Action — Faster
Delve into three examples that vividly showcase the formidable power of real-world evidence from the early stages of drug development through clinical trials and commercialization.
-
Software Development's Impact On Future Research And Tech
Unearth how modern software development in clinical research technology will shape the industry's future.